Still, these positive results can be enhanced when in combination with other drugs, such as metformin, which allows for an effective treatment plan with no increase in adverse symptoms usually seen with the treatment of semaglutide alone [121, 122, 125, 126]
NICE guideline CG189 (Obesity: identification, assessment and management) recommends that prescription-strength orlistat 120 mg be considered for adults with a BMI of 30 kg/m or above, or 28 kg/m or above in the presence of weight-related risk factors such as type 2 diabetes or hypertension, within a structured weight management programme
However, some side effects can arise from GLP-1 agonist use
The researchers say there are several reasons why people may not return to their original weight even a year after stopping the medications, including that they have developed healthier eating habits, such as reduced portion sizes or more nutritionally balanced meals